Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for
Lung Non-Small Cell Carcinoma
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase 2, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Tacoma WA, Seattle WA, Portland OR, San Francisco CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Location: Tacoma WA, Bellevue WA, San Diego CA, Sun City AZ,
Sponsor: Palisade Bio

Sex: All

Age: 18 - 70+

Code: NCT07845487

Phase 2, Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Tacoma WA, Bellevue WA, Silverdale WA, Las Vegas NV,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Tacoma WA, Vancouver, Coeur d'Alene ID, Boise ID,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for
Carcinoma, Non-Small Cell Lung,
Location: Tacoma WA, Seattle WA, Edmonds WA, Olympia WA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04389632

Phase 1, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Tacoma WA, Seattle WA, Bellevue WA, Vancouver, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Tacoma WA, Seattle WA, Bellevue WA, Vancouver, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

for
Multiple Myeloma, Multiple Myeloma Without Mention of Remission
Location: Seattle WA
Sponsor: All4Cure

Sex: All

Age: 18+

Code: NCT06149910

Recruiting

AIMS Cancer Outcomes Study

for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute

Sex: All

Age: 0+

Code: NCT04495790

Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Tacoma WA, Seattle WA, Boise ID, Calgary, Edmonton,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for
Crohn Disease, Colitis, Ulcerative
Location: Tacoma WA, Lubbock TX, Liberty MO, Southlake TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0+

Code: NCT06651281

Phase 3, Recruiting

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Tacoma WA, Seattle WA, Redwood City CA, Lancaster CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase 3, Recruiting

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Tacoma WA, Bellevue WA, Vancouver WA, Boise ID,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase 2, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Portland OR, Vancouver, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577856

Phase 3, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Tacoma WA, Portland OR, Vancouver, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577843

Phase 3, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Tacoma WA, Portland OR, Spokane WA, Boise ID,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase 2, Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Tacoma WA, Portland OR, Vancouver, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07196722

Phase 2, Phase 3, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: Tacoma WA, Vancouver, Idaho Falls ID, Northridge CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase 3, Recruiting